Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Crohn'S & Colitis|March 15, 2015
Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitisCrispin Corte, Nilesh Fernandopulle, Ana Maria Catuneanu, et al.Journal of Crohn'S & Colitis|September 21, 2016
Predicting the Individual Risk of Acute Severe Colitis at DiagnosisMonica Cesarini, Gary S Collins, Anders Rönnblom, et al.The Journal of Obstetrics and Gynaecology Research|May 8, 2019
New-onset ulcerative colitis in pregnancy associated to toxic megacolon and sudden fetal decompensation: Case report and literature reviewRoberto Brunelli, Seila Perrone, Giuseppina Perrone, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2013
Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective studyMonica Cesarini, Konstantinos Katsanos, Konstantinos Papamichael, et al.Journal of Crohn'S & Colitis|January 20, 2016
Perception of Reproductive Health in Women with Inflammatory Bowel DiseasePierre Ellul, Stephania Chectuti Zammita, Konstantinos H Katsanos, et al.European Journal of Gastroenterology & Hepatology|June 23, 2009
Internet use among inflammatory bowel disease patients: an Italian multicenter surveyErika Angelucci, Ambrogio Orlando, Sandro Ardizzone, et al.World Journal of Gastroenterology|May 20, 2017
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceShomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2022
Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled TrialShomron Ben-Horin, Ofir Har-Noy, Konstantinos H Katsanos, et al.Annals of Hematology|February 8, 2018
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, et al.Haematologica|February 2, 2015
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)Morena Caira, Anna Candoni, Luisa Verga, et al.Pageof 3